Clinical Trial Update: A Study in Subjects With Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update in subjects with moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ralexar Therapeutics (investigational)

Snippet

Sponsor: Ralexar Therapeutics, Inc. | Conditions: Atopic Dermatitis, Eczema, Atopic | Phase 2 | Status: COMPLETED